VentriPoint Diagnostics Ltd

TSXV:VPTCanadaView on OTCQB

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

Contact Information

Headquarters

18 Hook Ave, Unit 101TORONTO, ON, Canada M6P 1T4

Phone

416-848-4156

Fax

416-848-0709

Executives

Executive Chairman of the Board

George Adams

President, Chief Executive Officer

Alvira Macanovic

Chief Financial Officer

Jimmy Jeon

Independent Director

Randy AuCoin

Independent Director

Fiona Fitzgerald